High maternal BMI during pregnancy unlikely to cause fatness in childhood and adolescence

There is little evidence to support any long-term impact of maternal body mass index (BMI) in pregnancy on a child's risk of fatness in childhood and adolescence, according to a new study published in PLOS Medicine by Rebecca Richmond of the University of Bristol, UK, and colleagues.

Research has shown that a mother's BMI during pregnancy is associated with greater birth size of her offspring. However, whether this association continues through childhood and is mediated by processes that occur during gestation—such as effects of circulating glucose and lipids levels—had been unclear. In the new study, the researchers used body mass and genetic information on 6,057 mother-offspring pairs from two prospective birth cohort studies. In one cohort, the offspring's BMI was measured around age 6; in the other it was taken multiple times between ages 7 and 18.

While the researchers found associations between maternal BMI before pregnancy and offspring BMI at all ages, these associations were largely explained by transmission of genes associated with fatness. When a weighted genetic risk score was integrated into the analysis, the remaining association between pre-pregnancy BMI of a mother and her offspring's childhood BMI was nearly null. The study had limited power for some sensitivity tests, relied on self-reported pre-pregnancy BMI, and did not include any study of weight gain during pregnancy.

"These findings suggest that public health interventions directed at all family members and at different stages of the life course are likely to be important and are potentially more likely to halt the obesity epidemic than a focus on maternal overweight and obesity status in pregnancy," the authors say.

Comments

The Secret Science 02:The 30 Most Disturbing Human Experiments in History

Disturbing human experiments aren’t something the average person thinks too much about. Rather, the progress achieved in the last 150 years of human history is an accomplishment we’re reminded of almost daily. Achievements made in fields like biomedicine and psychology mean that we no longer need to worry about things like deadly diseases or masturbation as a form of insanity. For better or worse, we have developed more effective ways to gather information, treat skin abnormalities, and even kill each other. But what we are not constantly reminded of are the human lives that have been damaged or lost in the name of this progress. The following is a list of the 30 most disturbing human experiments in history. 30. The Tearoom Sex Study Sociologist Laud Humphreys often wondered about the men who commit impersonal sexual acts with one another in public restrooms. He wondered why “tearoom sex” — fellatio in public restrooms — led to the majority of homosexual arrests in ...

The Strange and Stranger Case of Wyndham Lathem

A Northwestern University plague researcher has been charged with a brutal murder. Here’s what we know about him. WIKIMEDIA, TONY WEBSTER O n July 27, The Chicago Tribune reported that there was an arrest warrant issued for Wyndham Lathem , a microbiologist at Northwestern University. The crime Lathem would later be charged with was brutal—26-year-old Trenton James Cornell-Duranleau, whose body was found in Lathem’s apartment, had been stabbed dozens of times. But Lathem was nowhere to be found. As events unfolded over the following days, it became clear he had fled from Chicago to California with a second suspect, 56-year-old Andrew Warren, a University of Oxford employee from the United Kingdom visiting the states. Along the way, the two men apparently made an anonymous $1,000 donation in Cornell-Duranleau’s name to the Lake Geneva Public Library and another donation for $5,610 to a Chicago health center. Lathem had also sent a video to fa...

Popular painkiller doesn’t have more heart risks than others, study claims

NEW ORLEANS — A long-awaited study on painkillers called nonsteroidal anti-inflammatory drugs, the most widely prescribed class of drugs in the world, has concluded that the three most commonly used carry a similar risk of cardiovascular complications. Yet critics say the study was too flawed to fairly compare them. Concerns about a type of NSAID called COX-2 inhibitors peaked in 2004 when the drug Vioxx was withdrawn from the market — a decision steeped in scandal because manufacturer Merck & Co had initially hidden data that would reveal the drug’s cardiovascular risks. A second COX-2 inhibitor, Pfizer Inc.’s Celebrex, was allowed to remain on the market with the condition that Pfizer conduct a study to prove that Celebrex was no worse than two older NSAIDs, naproxen and ibuprofen. The study lasted 10 years and enrolled more than 24,000 patients, but faced challenges. Doctors in European Union countries would not participate because they were worried a...

The Research

Search This Blog